New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients?

GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective ...

An analysis of more than 250,000 older adults diagnosed with metastatic non-small cell lung cancer showed only about half ...

Lung cancer is one of the kinds of cancer that is most likely to spread to the brain. Approximately 20 percent of lung cancer patients develop brain metastases. And roughly 10 to 20 percent of people ...

Black Diamond Therapeutics (NASDAQ:BDTX) reported updated Phase 2 data for silevertinib in treatment-naive non-small cell ...

About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in options over recent decades that have created meaningful improvements in lifespan ...

Outcomes of patients with concurrent chronic lymphocytic leukemia and non-small cell lung carcinoma. Circulating tumor DNA as a prognostic biomarker for long-term survival in de-novo oligometastatic ...

Deaths from cancer have fallen dramatically. They’ve dropped by 34% over the past three decades — largely thanks to better treatments, earlier detection, and fewer people smoking. But cancer ...

Breast metastasis from lung cancer is an uncommon yet clinically significant phenomenon that poses unique diagnostic and therapeutic challenges. Unlike primary breast carcinoma, these metastatic ...